AbbVie (ABBV) Change in Acquisitions & Divestments (2016 - 2025)
AbbVie (ABBV) has disclosed Change in Acquisitions & Divestments for 14 consecutive years, with $34.0 million as the latest value for Q4 2025.
- On a quarterly basis, Change in Acquisitions & Divestments fell 12.82% to $34.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $76.0 million, a 86.31% decrease, with the full-year FY2025 number at $76.0 million, down 86.31% from a year prior.
- Change in Acquisitions & Divestments was $34.0 million for Q4 2025 at AbbVie, up from $3.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $1.4 billion in Q3 2022 to a low of $3.0 million in Q2 2024.
- A 5-year average of $115.7 million and a median of $18.0 million in 2023 define the central range for Change in Acquisitions & Divestments.
- Peak YoY movement for Change in Acquisitions & Divestments: plummeted 99.65% in 2023, then soared 10040.0% in 2024.
- AbbVie's Change in Acquisitions & Divestments stood at $10.0 million in 2021, then surged by 600.0% to $70.0 million in 2022, then plummeted by 80.0% to $14.0 million in 2023, then surged by 178.57% to $39.0 million in 2024, then fell by 12.82% to $34.0 million in 2025.
- Per Business Quant, the three most recent readings for ABBV's Change in Acquisitions & Divestments are $34.0 million (Q4 2025), $3.0 million (Q3 2025), and $7.0 million (Q2 2025).